書誌事項
- タイトル別名
-
- A case of hepatocellular carcinoma treated with human fibroblast interferon (HuIFN-β)
- ヒト ベータガタ インターフェロン HuIFN ベータ トウヨ カン サイボウ
この論文をさがす
抄録
Human fibroblast interferon (HulFN-β) was administered by the intramuscular (total dose, 4671×104 international reference units, IU), intravenous (total dose, 2866×104IU), and intraarterial (total dose, 250×104 IU) routes in a 62-year-old man with hepatocellular carcinoma for 3 months. On admission, the mass of hepatocellular carcinoma was already recognized at all parts of the right lobe and a part of the left lobe and marked elevation of α-Fetoprotein level. The α-Fetoprotein level was decreased by the direct intrahepatic injection of HuIFN-β by the intraarterial route, but the size of the tumor wasgradually increased. No remarkable change was recognized by the intramuscular or intravenous ad-ministration. Only fever and the following subjective and objective symptoms were recognized as the side-effects of HulNF-β administration. Multinucleated giant cell transformation and a lack of a tendency to necrosis of the cancer cells were histopathologically recognized at the autopsy. These findings were, however, seen in some cases of hepatocellular carcinoma without the administration of HuIFN-β. Accordingly, we cannot but say that the therapeutic effect of HulFN-β on hepatocellular carcinoma are obscure in at least the present case.
収録刊行物
-
- 肝臓
-
肝臓 24 (2), 208-216, 1983
一般社団法人 日本肝臓学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679767010304
-
- NII論文ID
- 130000879100
-
- NII書誌ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL書誌ID
- 2623464
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可